ICU Medical (ICUI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Annual Meeting scheduled for May 13, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals by May 12, 2026.
Voting matters and shareholder proposals
Election of seven directors is up for shareholder vote, with all nominees recommended by the board.
Ratification of Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) is recommended for approval.
Proposal to amend the Certificate of Incorporation to adopt simple majority voting provisions.
Proposal to allow shareholders with 25% ownership to call special meetings, and a separate advisory proposal for a 10% threshold.
Board of directors and corporate governance
Seven director nominees listed for election, including Vivek Jain, David C. Greenberg, Elisha W. Finney, David F. Hoffmeister, Donald M. Abbey, Laurie Hernandez, and Kolleen T. Kennedy.
Latest events from ICU Medical
- Revenue up 8.6% year-over-year, but net loss widened and adjusted profitability declined.ICUI
Q2 20249 Jul 2026 - Q3 revenue up 6.5–7%, guidance raised, and Otsuka JV to transform IV Solutions business.ICUI
Q3 20249 Jul 2026 - Innovation and margin expansion are set to drive sustained growth and capital returns.ICUI
47th Annual Raymond James Institutional Investor Conference8 Jul 2026 - Growth in consumables and IV systems, innovation, and operational focus drive positive outlook.ICUI
Morgan Stanley 23rd Annual Global Healthcare Conference8 Jul 2026 - Adjusted EPS rose 15% to $1.97 as organic revenue grew 1% despite a 12% revenue decline.ICUI
Q1 202614 May 2026 - Directors and governance changes approved; 10% special meeting right proposal rejected.ICUI
AGM 202613 May 2026 - Margin expansion, pump upgrades, and consumables innovation drive a positive outlook.ICUI
2026 KeyBanc Capital Markets Healthcare Forum29 Apr 2026 - Infusion-focused growth, margin expansion, and share repurchases drive future value.ICUI
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - Shareholders will vote on directors, governance reforms, and executive pay, with ESG in focus.ICUI
Proxy filing2 Apr 2026